Our results suggest that hyperglycemia is important for development of inflammation and profibrotic processes in the liver, and we show here that insulin administration has beneficial effects on liver pathology and hepatic gene expression in a hyperglycemic, dyslipidemic hamster model of NAFLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.